{"commentary":{"count":4,"free_build_floor":8,"listing_floor":3,"by_channel":{"youtube":2,"podcast":2},"note":"Indexed podcasts, YouTube videos and X posts that name this trial. A report screens them, searches for more and cites what clinicians said when it is built."},"free_build":{"available":false},"name":"VERSATILE-003","nct_id":"NCT06790966","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=versatile-003-nct06790966. The price is fixed at order. We build the report after the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–12 commentary sources"},"registry":{"acronym":"VERSATILE-003","arms":[{"description":"PDS0101 + Pembrolizumab","label":"Interventional Arm","type":"EXPERIMENTAL"},{"description":"Pembrolizumab","label":"Control Arm","type":"ACTIVE_COMPARATOR"}],"collaborators":[],"completion_date":{"date":"2026-08-25","type":"ACTUAL"},"conditions":["Recurrent Head and Neck Cancer","Metastatic Head and Neck Cancer","HPV Positive Oropharyngeal Squamous Cell Carcinoma","Neoplasms, Head and Neck","Unresectable Head and Neck Squamous Cell Carcinoma"],"enrollment":{"count":12,"type":"ACTUAL"},"has_results":false,"interventions":[{"name":"Combination Treatment of PDS0101 and Pembrolizumab","type":"COMBINATION_PRODUCT"},{"name":"Pembrolizumab Monotherapy","type":"DRUG"}],"last_update":"2026-09-02","lead_sponsor":"PDS Biotechnology Corp.","official_title":"A Phase 3 Open-Label, Randomized Study of PDS0101 and Pembrolizumab vs Pembrolizumab Alone in First-Line Treatment of Unresectable Recurrent and/or Metastatic HPV16+ Head and Neck Squamous Cell Carcinoma","overall_status":"TERMINATED","phases":["PHASE3"],"primary_completion_date":{"date":"2026-08-25","type":"ACTUAL"},"primary_outcomes":[{"measure":"Overall Survival (OS)","timeFrame":"Up to 54 months"},{"measure":"Progression-Free Survival (PFS)","timeFrame":"Up to 18 months"}],"references":[],"start_date":{"date":"2025-05-30","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma","url":"https://clinicaltrials.gov/study/NCT06790966"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"2.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/versatile-003-nct06790966"}